The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Tizona Therapeutics, Inc
IDEAYA Biosciences
Maastricht University Medical Center
Seagen Inc.
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Evopoint Biosciences Inc.
Kineta Inc.
Xencor, Inc.